Institutional investors purchased a net $254.2 thousand shares of AMRI during the quarter ended June 2014. This may signal that the smart money is gaining interest in this company as the 88.76% of shares outstanding that institutional investors hold is actually below the Services to the Health Industry industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY & CO. LLC Bought 1.0 Million shares of Albany Molecular Research...
FRANKLIN STREET ADVISORS, INC. Bought 23.8 Thousand shares of Albany Molecular Research...